Our in vitro results indicate that both pharmacologically inhibiting class I HDACs with Tac and silencing both HDAC2 and HDAC3 constitute relevant neuroprotective strategies in AD hippocampal neural cells. Here, HDAC3 is linked to Alzheimer disease.